NRLCX | VIVIX | NRLCX / VIVIX | |
Total Expense Ratio | 0.51 | 0.04 | 1,275% |
Annual Report Gross Expense Ratio | 0.51 | 0.04 | 1,275% |
Fund Existence | 7 years | 27 years | - |
Gain YTD | 9.261 | 6.730 | 138% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 195B | 4% |
Annual Yield % from dividends | 2.27 | 2.19 | 104% |
Returns for 1 year | 10.63 | 9.75 | 109% |
Returns for 3 years | 28.79 | 34.32 | 84% |
Returns for 5 years | 81.87 | 74.87 | 109% |
Returns for 10 years | N/A | 116.26 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IUAIX | 45.04 | 0.20 | +0.45% |
VY® Invesco Equity and Income I | |||
LSAGX | 23.61 | 0.10 | +0.43% |
Loomis Sayles Global Growth A | |||
CGFEX | 81.26 | 0.27 | +0.33% |
American Funds Growth Fund of Amer 529E | |||
SMVLX | 78.61 | 0.24 | +0.31% |
Smead Value Investor | |||
TPISX | 13.39 | -0.05 | -0.37% |
Nuveen Quant Intl Small Cap Eq Premier |